Harry H. Penner, Jr.
Chairman
Celldex Therapeutics, Inc. (CLDX)Board Member
Celldex Therapeutics, Inc. (CLDX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Harry H. Penner, Jr.
Harry H. Penner, Jr. is recorded as Chairman and Board Member at Celldex Therapeutics, Inc. (CLDX). Celldex Therapeutics, Inc. reported in an 8-K filed June 6, 2025 that Harry H. Penner, Jr. was appointed director, effective June 5, 2025. Celldex Therapeutics, Inc. reported in an 8-K filed June 6, 2025 that Harry H. Penner, Jr. was appointed Chair of the Company’s board of directors, effective June 5, 2025. Celldex Therapeutics, Inc. reported in an 8-K filed June 14, 2024 that Harry H. Penner, Jr. was appointed Director, effective June 13, 2024.
“The stockholders elected the following individuals to serve on the Company’s board of directors until the annual meeting of stockholders to be held in 2026.”
“Subsequent to the Annual Meeting, the Company’s board of directors convened on June 5, 2025 and elected Harry H. Penner, Jr., as Chair of the Company’s board of directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-25–present
-
Current
2024-06-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Celldex Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Anthony Marucci CEO, Board Member
- Anthony S. Marucci CEO, Board Member
- Karen L. Shoos Chairman
- Freddy A. Jimenez, Esq. General Counsel
- Freddy Jimenez General Counsel
- Cheryl L. Cohen Board Member
- Denice Torres Board Member
- Garry A. Neil, M.D. Board Member
- Herbert J. Conrad Board Member
- James J. Marino Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.